Associated Papers
Characterisation of pharmacogenomic variation in the Shetland and Orkney Isles in Scotland.
Twesigomwe D et al.
Scientific Reports, 2025
StarPhase: Comprehensive Phase-Aware Pharmacogenomic Diplotyper for Long-Read Sequencing Data.
Holt JM et al.
Biorxiv : the Preprint Server for Biology, 2024
39713404 (PubMed )
Supplement: media-1.pdf
Comprehensive overview of the pharmacogenetic diversity in Ashkenazi Jews.
Zhou Y et al.
Journal of Medical Genetics, 2018
The Affymetrix DMET Plus platform reveals unique distribution of ADME-related variants in ethnic Arabs.
Wakil SM et al.
Disease Markers, 2015
25802476 (PubMed )
Supplement: 542543.f1.xlsx › DMET_Suppl_data
Potentially functional SNPs (pfSNPs) as novel genomic predictors of 5-FU response in metastatic colorectal cancer patients.
Wang J et al.
Plos One, 2014
25372392 (PubMed )
Supplement: pone.0111694.s006.pdf
Do single nucleotide polymorphisms in xenobiotic metabolizing genes determine breast cancer susceptibility and treatment outcomes?
Singh V et al.
Cancer Investigation, 2008
Predicting drug response and toxicity based on gene polymorphisms.
Robert J et al.
Critical Reviews in Oncology/hematology, 2005
Overview of the pharmacogenetics of HIV therapy.
Rodríguez-Nóvoa S et al.
The Pharmacogenomics Journal, 0
Select a paper to view details